Ubs Group Ag Grifols Sa Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Grifols Sa stock. As of the latest transaction made, Ubs Group Ag holds 1,868,493 shares of GRFS stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,868,493
Previous 942,911
98.16%
Holding current value
$13.9 Million
Previous $8.37 Million
66.02%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding GRFS
# of Institutions
169Shares Held
145MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$157 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$153 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$121 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$83.8 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$74.8 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.06B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...